Advertisement
Person › Details
Christan Itin (Autolus Therapeutics Ltd.)
Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc)
Organisation | Autolus Therapeutics Ltd. | |
Today | Autolus Therapeutics plc (Nasdaq: AUTL) | |
Group | Autolus Therapeutics plc (Nasdaq: AUTL) | |
Former/major organisation | Micromet AG | |
Today | Amgen Research (Munich) GmbH | |
Group | Amgen (Group) | |
Product | T cell therapy | |
Product 2 | blinatumomab (AMG 103/MT103/MEDI-538) | |
Record changed: 2024-03-01 |
Advertisement
More documents for Christan Itin
- [1] BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London....
- [2] Autolus Ltd.. (4/4/18). "Press Release: Autolus and Miltenyi Biotec Sign Strategic Supply Agreement". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top